Biotage AB Statistics

Total Valuation

Biotage AB has a market cap or net worth of GBP 827.37 million. The enterprise value is 818.64 million.

Market Cap	827.37M
Enterprise Value	818.64M

Important Dates

The next estimated earnings date is Wednesday, February 19, 2025.

Earnings Date	Feb 19, 2025
Ex-Dividend Date	Apr 26, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+13.55%
Shares Change (QoQ)	+0.08%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	66.34M

Valuation Ratios

The trailing PE ratio is 43.76.

PE Ratio	43.76
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	14.90
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.50, with an EV/FCF ratio of 33.93.

EV / Earnings	43.30
EV / Sales	5.31
EV / EBITDA	21.50
EV / EBIT	30.48
EV / FCF	33.93

Financial Position

The company has a current ratio of 1.91, with a Debt / Equity ratio of 0.07.

Current Ratio	1.91
Quick Ratio	1.15
Debt / Equity	0.07
Debt / EBITDA	0.48
Debt / FCF	0.76
Interest Coverage	14.76

Financial Efficiency

Return on equity (ROE) is 6.85% and return on invested capital (ROIC) is 5.65%.

Return on Equity (ROE)	6.85%
Return on Assets (ROA)	4.68%
Return on Invested Capital (ROIC)	5.65%
Return on Capital Employed (ROCE)	8.75%
Revenue Per Employee	230,715
Profits Per Employee	28,008
Employee Count	674
Asset Turnover	0.43
Inventory Turnover	1.59

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -6.68% in the last 52 weeks. The beta is 0.91, so Biotage AB's price volatility has been similar to the market average.

Beta (5Y)	0.91
52-Week Price Change	-6.68%
50-Day Moving Average	151.90
200-Day Moving Average	171.01
Relative Strength Index (RSI)	44.78
Average Volume (20 Days)	4,930

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biotage AB had revenue of GBP 155.73 million and earned 18.91 million in profits. Earnings per share was 0.24.

Revenue	155.73M
Gross Profit	97.32M
Operating Income	27.14M
Pretax Income	24.06M
Net Income	18.91M
EBITDA	36.19M
EBIT	27.14M
Earnings Per Share (EPS)	0.24

Full Income Statement

Balance Sheet

The company has 27.22 million in cash and 18.39 million in debt, giving a net cash position of 8.83 million.

Cash & Cash Equivalents	27.22M
Total Debt	18.39M
Net Cash	8.83M
Net Cash Per Share	n/a
Equity (Book Value)	280.27M
Book Value Per Share	3.50
Working Capital	43.40M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 29.87 million and capital expenditures -5.74 million, giving a free cash flow of 24.13 million.

Operating Cash Flow	29.87M
Capital Expenditures	-5.74M
Free Cash Flow	24.13M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 62.49%, with operating and profit margins of 17.43% and 12.14%.

Gross Margin	62.49%
Operating Margin	17.43%
Pretax Margin	15.45%
Profit Margin	12.14%
EBITDA Margin	23.24%
EBIT Margin	17.43%
FCF Margin	15.49%

Dividends & Yields

Biotage AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	-5.58%
Years of Dividend Growth	n/a
Payout Ratio	49.81%
Buyback Yield	-13.55%
Shareholder Yield	-13.55%
Earnings Yield	2.29%
FCF Yield	2.92%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Biotage AB has an Altman Z-Score of 8.41.

Altman Z-Score	8.41
Piotroski F-Score	n/a